Prevalence and mortality of cancer among HIV-infected inpatients in Beijing, China

BMC Infectious Diseases

Volumn 16, Issue 1, 2016, Pages

  Yang, Jun ^a   Su, Shu ^b   Zhao, Hongxin ^c   Wang, Dennis ^d   Wang, Jiali ^b   Zhang, Fujie ^c   Zhao, Yan ^b  

^a CANCER HOSPITAL   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d YALE UNIVERSITY   (United States)

Author keywords

Antiretroviral therapy; Cancer; China; Concurrence; HIV; Mortality; Prevalence

Indexed keywords

ADULT; AIDS DEFINING CANCER; ANTIRETROVIRAL THERAPY; ANTIVIRAL THERAPY; ARTICLE; CANCER SURVIVAL; CD4 LYMPHOCYTE COUNT; CHINA; COHORT ANALYSIS; DIGESTIVE SYSTEM CANCER; DISEASE ASSOCIATION; FEMALE; HODGKIN DISEASE; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LIVER CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; NEOPLASM; NON AIDS DEFINING CANCER; PREVALENCE; RETROSPECTIVE STUDY; RISK FACTOR; AGED; COMPLICATION; FOLLOW UP; HOSPITALIZATION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPLAN MEIER METHOD; NEOPLASMS; PROPORTIONAL HAZARDS MODEL; STATISTICAL MODEL; VERY ELDERLY; VIROLOGY;

ADULT; AGED; AGED, 80 AND OVER; CHINA; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HOSPITALIZATION; HUMANS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASMS; PREVALENCE; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84957971904     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-016-1416-3     Document Type: Article

References (29)

1. Biggar RJ, Chaturvedi AK, Goedert JJ, Engels EA. AIDS-related cancer and severity of immunosuppression in persons with AIDS. J Natl Cancer Inst. 2007;99(12):962-72.
2. Coghill AE, Shiels MS, Suneja G, Engels EA. Elevated Cancer-Specific Mortality Among HIV-Infected Patients in the United States. J Clin Oncol. 2015;33(21):2376-2383.
3. Riedel DJ, Mwangi EI, Fantry LE, Alexander C, Hossain MB, Pauza CD, et al. High cancer-related mortality in an urban, predominantly African-American, HIV-infected population. AIDS (London, England). 2013;27(7):1109-17.
4. Yanik EL, Napravnik S, Cole SR, Achenbach CJ, Gopal S, Olshan A, et al. Incidence and timing of cancer in HIV-infected individuals following initiation of combination antiretroviral therapy. Clin Infect Dis. 2013;57(5):756-64.
5. Pinzone MR, Fiorica F, Di Rosa M, Malaguarnera G, Malaguarnera L, Cacopardo B, et al. Non-AIDS-defining cancers among HIV-infected people. Eur Rev Med Pharmacol Sci. 2012;16(10):1377-88.
6. Engels EA, Biggar RJ, Hall HI, Cross H, Crutchfield A, Finch JL, et al. Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer J Int Du Cancer. 2008;123(1):187-94.
7. Deeken JF, Tjen ALA, Rudek MA, Okuliar C, Young M, Little RF, et al. The rising challenge of non-AIDS-defining cancers in HIV-infected patients. Clin Infect Dis. 2012;55(9):1228-35.
8. International Collaboration on HIV and Cancer. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Inst. 2000;92(22):1823-30.
9. Clifford GM, Polesel J, Rickenbach M, Dal Maso L, Keiser O, Kofler A, et al. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst. 2005;97(6):425-32.
10. Jones JL, Hanson DL, Dworkin MS, Ward JW, Jaffe HW. Effect of antiretroviral therapy on recent trends in selected cancers among HIV-infected persons. Adult/Adolescent Spectrum of HIV Disease Project Group. J Acquir Immune Defic Syndr. 1999;21 Suppl 1:S11-7.
11. Sackoff JE, Hanna DB, Pfeiffer MR, Torian LV. Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City. Ann Intern Med. 2006;145(6):397-406.
12. Spagnuolo V, Galli L, Salpietro S, Gianotti N, Guffanti M, Cossarini F, et al. Ten-year survival among HIV-1-infected subjects with AIDS or non-AIDS-defining malignancies. Int J Cancer J Int Du Cancer. 2012;130(12):2990-6.
13. Hleyhel M, Belot A, Bouvier AM, Tattevin P, Pacanowski J, Genet P, De Castro N, Berger JL, Dupont C, Lavole A et al. Trends in survival after cancer diagnosis among HIV-infected individuals between 1992 and 2009. Results from the FHDH-ANRS CO4 cohort. Int J Cancer J Int Du Cancer. 2015;137(10):2443-2453.
14. Gotti D, Raffetti E, Albini L, Sighinolfi L, Maggiolo F, Di Filippo E, et al. Survival in HIV-infected patients after a cancer diagnosis in the cART Era: results of an italian multicenter study. PLoS One. 2014;9(4):e94768.
15. Aberg JA. The changing face of HIV care: common things really are common. Ann Intern Med. 2006;145(6):463-5.
16. Falster K, Choi JY, Donovan B, Duncombe C, Mulhall B, Sowden D, et al. AIDS-related and non-AIDS-related mortality in the Asia-Pacific region in the era of combination antiretroviral treatment. AIDS (London, England). 2009;23(17):2323-36.
17. Zhang F, Dou Z, Ma Y, Zhang Y, Zhao Y, Zhao D, et al. Effect of earlier initiation of antiretroviral treatment and increased treatment coverage on HIV-related mortality in China: a national observational cohort study. Lancet Infect Dis. 2011;11(7):516-24.
18. Fisher M. Late diagnosis of HIV infection: major consequences and missed opportunities. Curr Opin Infect Dis. 2008;21(1):1-3.
19. Tang H, Mao Y, Shi CX, Han J, Wang L, Xu J, et al. Baseline CD4 cell counts of newly diagnosed HIV cases in China: 2006-2012. PLoS One. 2014;9(6):e96098.
20. Grulich AE, Wan X, Law MG, Coates M, Kaldor JM. Risk of cancer in people with AIDS. AIDS (London, England). 1999;13(7):839-43.
21. Layton JL, Castillo JJ. Non-AIDS defining cancers. Med Health Rhode Island. 2010;93(10):296-8.
22. Zhang YX, Gui XE, Zhong YH, Rong YP, Yan YJ. Cancer in cohort of HIV-infected population: prevalence and clinical characteristics. J Cancer Res Clin Oncol. 2011;137(4):609-14.
23. Sigel K, Dubrow R, Silverberg M, Crothers K, Braithwaite S, Justice A. Cancer screening in patients infected with HIV. Curr HIV/AIDS Rep. 2011;8(3):142-52.
24. Chen W, Zheng R, Zhang S, Zhao P, Zeng H, Zou X, et al. Annual report on status of cancer in China. Chin J Cancer. 2010;26(1):48-58.
25. Shiels MS, Pfeiffer RM, Gail MH, Hall HI, Li J, Chaturvedi AK, et al. Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst. 2011;103(9):753-62.
26. Mutyaba I, Phipps W, Krantz EM, Goldman JD, Nambooze S, Orem J, et al. A population-level evaluation of the effect of antiretroviral therapy on cancer incidence in Kyadondo County, Uganda, 1999-2008. J Acquir Immune Defic Syndr. 2015;69(4):481-6.
27. Grulich AE. Cancer: the effects of HIV and antiretroviral therapy, and implications for early antiretroviral therapy initiation. Curr Opin HIV AIDS. 2009;4(3):183-7.
28. Simard EP, Engels EA. Cancer as a cause of death among people with AIDS in the United States. Clin Infect Dis. 2010;51(8):957-62.
29. Long JL, Engels EA, Moore RD, Gebo KA. Incidence and outcomes of malignancy in the HAART era in an urban cohort of HIV-infected individuals. AIDS (London, England). 2008;22(4):489-96.